Sandoz Group AG Sponsored ADR (SDZNY)
(Delayed Data from OTC)
$35.49 USD
+0.45 (1.28%)
Updated May 31, 2024 03:59 PM ET
4-Sell of 5 4
B Value B Growth D Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
SDZNY 35.49 +0.45(1.28%)
Will SDZNY be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for SDZNY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SDZNY
AbbVie (ABBV) Q4 Earnings Beat, Raises Sales View for Key Drugs
AbbVie (ABBV) Q3 Earnings Beat, Shares Down Despite Raised View
SDZNY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for SDZNY
Sandoz receives EC approval for Wyost, Jubbonti in Europe
Sandoz receives European Commission approval for Wyost® and Jubbonti®, the first and only biosimilars of denosumab in Europe
Sandoz price target raised by CHF 3 at Berenberg
Diamond Hill International Fund Q1 2024 Market Commentary
Sandoz price target raised by CHF 3 at JPMorgan